FDA Panelists Slam Agency’s Proposed Opioid Trial Design https://www.medpagetoday.com/painmanagement/opioids/104117 Advisors said outcomes from an enriched enrollment study would not be broadly generalizable FDA advisors recommended that the agency reconsider its planned postmarketing trial design to evaluate the long-term efficacy and tolerability of opioids in chronic pain patients. Without holding a vote on Wednesday, the Anesthetic and […]
Filed under: General Problems | 2 Comments »